Search Results

[ NEWS ] SDT Molecular appointed sole distributor for QCMD 2018-10-01 Quality Control for Molecular Diagnostics (QCMD) is an independent International External Quality Assessment (EQA) / Proficiency Testing (PT) organisation. QCMD provides a wide-ranging quality assessment service primarily focused on molecular infectious diseases to over 2000 participants in over 100 countries. [ NEWS ] SDT Molecular appointed sole distributor for Qnostics 2018-09-26 Qnostics is a leading provider of infectious diseases molecular quality controls for use within the standard procedures of today’s molecular laboratory and assay manufacturers. [ NEWS ] Registered first CE-IVD product with HSA 2017-09-14 Successfully registered our 1st CE-IVD product with Health Science Authority (HSA) on 14 September 2017.altona Diagnostics:RealStar Malaria PCR Kit 1.0, Class C IVD [ NEWS ] SDT Molecular obtained sole distributionship of 5 brand of diagnostic assays 2018-09 Obtained sole distribution of 5 CE-IVD products: altona Diagnostics (Germany) Certest Biotech (Spain) Master Diagnostica (Spain) Pathofinder (Netherlands) Pathonostics (Netherlands) Page > 1 2 3

Inherited Disease Testing INTROL® Control Panel Cystic Fibrosis Panel I Control Cystic Fibrosis Panel II Control Cystic Fibrosis Panel III Control Cystic Fibrosis Panel I Control v.02 Hereditary Hemochromatosis Panel I Control Hereditary Hemochromatosis Panel II Control Thrombosis Genotype Panel Thrombotic Risk Genotype Control GeneXpert Control Panel Xpert FII & FV Genotype Panel G109 Xpert FII & FV HET Xpert FII & FV NOR/MUT Control ​ ​ NGS CF Control Panel G211 v1.1 ​​ The cGMP-grade controls comprise of synthetic DNA/RNA suspension in non-infectious solution of buffers, preservatives and stabilizers, are made to mimic clinical specimens under laboratory conditions. Intended for in-vitro use as an external control to monitor the nucleic acid detection of genetic markers causing inherited diseases. ​ ❮ BACK TO MMQCI MAIN Inherited Disease Testing Infectious Disease Testing ePlex Control Panel BCID-FP Control M320 v1.1 BCID-GP Control M323 v1.1 BCID-GN Control M326 RP Control M306 RP2 Control M451 SARS-CoV-2 Control Panel M435 BioFire / FilmArray® Control Panel RP Control Panel M210 v1.1 RP EZ Control Panel M265 RP2.1/RP2.1plus Control Panel M441 BCID Control Panel M235 v1.1 BCID2 Control Panel M416 GI Control Panel M238 Ebola Control Panel M251 Pneumonia/Pneumoniaplus Control M340 JI Control Panel M420 GeneXpert Control Panel Carba-R QC Panel M219RP EZ Control Panel M265 SARS-CoV-2 Control Panel M430 INTROL® Control Panel ME Control Panel M262 TB Panel M110 TB Panel M114 TB Panel M114plus TB-XDR Panel M345 TBNEG-30 Unyvero LRT Control Panel LRT/Pneumonia Control Panel M404 LRT Verification Panel M408 eSensor® XT-8™ RVP Control Panel QIAstat-Dx RP SARS-CoV-2 Control Panel Verigene® RP Flex Control Panel M270el The cGMP-grade controls comprise of synthetic DNA/RNA suspension in non-infectious solution of buffers, preservatives and stabilizers, are made to mimic clinical specimens under laboratory conditions. Intended for in-vitro use as an external control to monitor the nucleic acid detection of causative pathogens in infectious diseases. ❮ BACK TO MMQCI MAIN Infectious Disease Testing Oncology Testing GeneXpert Control Panel BCR-ABL IS Panel C130 BCR-ABL 0%IS Bladder Cancer Panel C104 INTROL® BCR-ABL1 p190 Control Panel The cGMP-grade controls comprise of synthetic DNA/RNA suspension in non-infectious solution of buffers, preservatives and stabilizers, are made to mimic clinical specimens under laboratory conditions. Intended for in-vitro use as an external control to monitor the nucleic acid detection of genetic markers in oncology testing. ❮ BACK TO MMQCI MAIN Oncology Testing Pharmacogenomics Testing INTROL® Control Panel 2C19 Panel P105 2C19 Panel P110 PGx 1 Control The cGMP-grade controls comprise of synthetic DNA/RNA suspension in non-infectious solution of buffers, preservatives and stabilizers, are made to mimic clinical specimens under laboratory conditions. Intended for in-vitro use as an external control to monitor the nucleic acid detection of genetic markers in pharmacogenomic testing. ❮ BACK TO MMQCI MAIN Pharmacogenomics Testing SARS-CoV-2 Testing BioFire RP2.1/RP2.1plus Control Panel M441 QIAstat-Dx RP SARS-CoV-2 Control Panel Xpert SARS-CoV-2 Control Panel M430 ePlex Control Panel SARS-CoV-2 Control Panel M435 ePlex RP2 Control M451 The cGMP-grade controls comprise of synthetic DNA/RNA suspension in non-infectious solution of buffers, preservatives and stabilizers, are made to mimic clinical specimens under laboratory conditions. Intended for in-vitro use as an external control to monitor the nucleic acid detection of SARS-CoV-2 virus. ❮ BACK TO MMQCI MAIN SARS-CoV-2 Testing

Blood Borne Virus Hepatitis B Virus Genotype Hepatitis C Virus Genotype Hepatitis E Virus Human Immunodeficiency Virus I Central Nervous System Meningitis / Encephalitis (ME) Gastrointestinal Diseases Viral: Norovirus GI, Norovirus GII, Adenovirus Type 41, Rotavirus, Astrovirus, Sapovirus Bacterial-Parasite: Campylobacter jejuni, Campylobacter lari, Clostridium difficile 027, Shigella flexneri, Salmonella enteritidis, Yersinia enterolitica, Giardia lamblia, Cryptosporidium parvum, Entamoeba histolytica, Plesiomonas shigelloides Pathogenic E. coli: E.coli 0157, Shiga toxin-producing E.coli, Enterotoxigenic E.coli Respiratory Diseases INFA - H1N1, INFA - H3N2, INFB - Victoria, RSV - Type A, RSV - Type B Sexual Transmitted Diseases Trichomonas vaginalis Mycoplasma genitalium Mycoplasma hominis Ureaplasma urealyticum Gardnerella vaginalis Neisseria gonorrhoea Chlamydia trachomatis Fungal Infection Candida spp Aspergillus spp Evaluation Panels Evaluation Panels Verification and Validation panels are designed to evaluate and establish the assay parameters of the molecular method and determine its fitness for purpose: Used for verification and validation of clinical assays, development of diagnostic tests and training of laboratory personnel. Designed to confirm any performance claims and suitability for the laboratories testing requirements. Where appropriate, calibrated against a WHO International Standard or Internal Reference Material, all quantified by digital PCR. These panels contain a 3 panel linearity series and also a duplicate sample. Some of these panels also contain different genotypes – as it varies by panel. ​ ❮ BACK TO QNOSTICS MAIN QCMD Past Panels QCMD past panels are highly characterised Quality Assessment materials that have been used within previous QCMD International EQA / PT schemes. They are extremely helpful in post EQA evaluations and provide an additional source of quality material. Qnostics as a distribution partner of QCMD, is able to provide the EQA panel materials and accompanying EQA summaries to customers outside of the active QCMD EQA programmes once they have closed. ​ ❮ VIEW QCMD PAST PANELS ❮ BACK TO QNOSTICS MAIN QCMD Past Panels

[ WEBINAR ] Non-Invasive Fetal-RHD testing 2022-09-08 Non-invasive detection of fetal RHD status is vital to enable targeted prophylaxis to mothers at risk, eliminating unnecessary administration of human blood-based products while reducing immunization. READ MORE [ WEBINAR ] The clinical importance of post-transplantation monitoring 2022-06-07 Following a successful transplantation, there are still obstacles to overcome for many years ahead. Losing that aftermath is not only deeply tragic but unnecessary. READ MORE Page > 1

[ EVENT] ] PHS Health Screening Event 2022 2022-08-20 Led by students from the NUS Yong Loo Lin School of Medicine, the Public Health Service (PHS) team has been offering public health screening events since 2004. READ MORE [ EVENT ] Singapore Molecular Diagnostic Symposium 2018 2018-04-19/20 The theme of this symposium is "Genomics in Healthcare". It was held at The Star Loft at The Star Performing Arts Centre from 19-20 April, 2018. Thank you MDC@NUH for giving us the opportunity to showcase our portfolio and catch-up with friends, customer and partners. The entire two days were truly enjoyable. [ EVENT ] MEDLAB Asia Pacific 2018 2018-04-2-4 The inaugural MEDLAB Asia Pacific Exhibition & Congress was launched in February 2014 as part of the MEDLAB series. Now in its fifth year, the exhibition will provide a platform for leading companies to showcase current technologies and clever innovations in the field of laboratory and diagnostics. This year, we are glad that 2 of our new partners from Spain, Certest Biotec and Master Diagnostica were here to showcase their products. Page > 1

【 PRODUCT 】 Quality Assurance and Quality Control for Diagnostic Work 2022-05-27 SDT Molecular realises the importance and offers a wide range of solutions for Quality Assurance and Quality Control, for laboratories to uphold their diagnostic tests at the highest quality standards. Ranging from proficiency tests in Pathology and molecular controls, we provide the ideal solutions for your diagnostic needs. READ MORE Page > 1 2

[ ANNOUNCEMENT ] Yourgene Health receives HSA approval for IONA Nx NIPT Workflow in Singapore 2022-09-29 SDT is proud to announce that Yourgene Health has received Health Sciences Authority (HSA) approval for their IONA® Nx NIPT Workflow in Singapore. The prenatal screening workflow has been authorised for use in clinical laboratories, providing them with a fully automated and cost-effective testing solution to establish their own fast, accurate and quality-assured non-invasive prenatal testing (NIPT) service. Click below to read the press release. READ MORE [ ANNOUNCEMENT ] RCPA 2023 Enrolments Now Open! 2022-09-19 The Royal College of Pathologists of Australasia Quality Assurance Programs (RCPAQAP) are world leaders in the provision of external quality assurance (EQA) for pathology laboratories. They offer a comprehensive range of EQA for all disciplines of pathology including Molecular Genetics, Biosecurity and Point-of-Care. RCPAQAP is committed to providing an efficient and customer-focused service to participants. CONTACT US Page > 1

[ NEW PRODUCT ] 3-in-1 Automated Gel Electrophoresis System 2022-08-22 The Yourgene’s LightBench® provides automated size selection and can be further seamlessly leveraged to provide high throughput fragment length analysis and fluorescence quantitation. READ MORE [ NEW PRODUCT ] altona launches FlexStar® Monkeypox virus (RUO) 2022-07-12 In 2022, multiple cases of monkeypox were identified in several non-endemic regions. Responding to laboratory demand, the FlexStar® Monkeypox virus PCR Detection Mix 1.5. (RUO) from altona Diagnostics. READ MORE [ PRODUCT ] Prenatal Aneuploidy Diagnosis 2022-07-04 Non-invasive prenatal tests (NIPT) are widely used to screen for chromosomal abnormalities in fetus. Devyser offers a range of diagnostic kits (CE-IVD) for the rapid diagnosis of pregnancies at increased risk of aneuploidy in chromosomes 13, 18, 21, X or Y. READ MORE [ NEW PRODUCT ] RealStar® Zoonotic Orthopoxvirus PCR Kit 1.0 2022-06-09 We are pleased to announce the launch of the RealStar® Zoonotic Orthopoxvirus PCR Kit 1.0. The kit is now available as a Research use Only (RUO) product. The RealStar® Zoonotic Orthopoxvirus PCR Kit 1.0 is based on real-time PCR technology, detects for zoonotic Orthopoxvirus species specific DNA (including monkeypox). READ MORE Page > 1 2

Blood Borne Virus B19 virus Central Nervous System BK Virus JC Virus Herpes Simplex Virus 1 (HSV1) Herpes Simplex Virus 2 (HSV2) Varicella Zoster Virus Congenital Infections Cytomegalovirus Gastrointestinal Diseases Adenovirus Immuno-compromised Associated Diseases BK Virus JC Virus Cytomegalovirus Epstein-Barr virus Human herpes virus 6 Respiratory Diseases Adenovirus Influenza A virus Influenza B virus Parainfluenza Virus Rhinovirus SARS-CoV-2 Respiratory syncytial virus A Respiratory syncytial virus B Sexual Transmitted Diseases Herpes simplex virus 1 Herpes simplex virus 2 Transplant Associated Diseases BK Virus JC Virus Adenovirus Cytomegalovirus Epstein-Barr virus Human herpes virus 6 Analytical Q Panels Qnostics’ Analytical Q Panels are designed to cover the dynamic range of an assay allowing the laboratory to assess the linearity, LOD and LOQ of their assay. Each panel contains five or more individual samples covering the dynamic range of individual infectious disease assays, in a linear progression. Analytical Q Panels are intended for use in the validation and verification of new assays with the main purpose of helping to ensure assays are linear throughout the dynamic range. Analytical Q Panels will support a laboratory’s accreditation requirements, in line with ISO 15189:2012. ​ ❮ BACK TO QNOSTICS MAIN

Blood Borne Virus B19 virus Hepatitis A virus Central Nervous System BK Virus JC Virus Herpes Simplex Virus 1 (HSV1) Herpes Simplex Virus 2 (HSV2) Varicella Zoster Virus Congenital Infections Cytomegalovirus Gastrointestinal Diseases Adenovirus Norovirus GI Norovirus GII Immuno-compromised Associated Diseases BK Virus JC Virus Cytomegalovirus Epstein-Barr virus Human herpes virus 6 Respiratory Diseases Adenovirus SARS-CoV-2 Sexual Transmitted Diseases Herpes simplex virus 1 Herpes simplex virus 2 Chlamydia trachomatis Neisseria gonorrhoea Transplant Associated Diseases BK Virus JC Virus Adenovirus Cytomegalovirus Epstein-Barr virus Human herpes virus 6 Molecular Q Panels Qnostics’ Molecular Q Panels are intended to help laboratories evaluate their assays’ analytical measurement parameters and monitor molecular diagnostic assay procedures. The panels can also be used to support laboratory training and in the assessment and development of molecular diagnostic assays from extraction phase through amplification to detection. Designed to help a laboratory validate a new assay or instrument to ensure that everything is performing as expected. Ideal for testing linearity, these panels contain 4 samples – a high, medium, low and a negative sample. Similar to the Q Controls, the Molecular Q Panels are unassayed and for single use only. ​ ❮ BACK TO QNOSTICS MAIN